Does Oregon Health and Science University (OHSU) require a 24-hour urine test for transplant candidates, similar to University of Washington (UW)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Institution-Specific Transplant Requirements

I cannot answer this question based on the evidence provided, as none of the available guidelines or research studies address institution-specific pre-transplant evaluation protocols for Oregon Health and Science University (OHSU) or University of Washington (UW).

Why This Question Cannot Be Answered from Clinical Guidelines

The evidence provided consists entirely of:

  • KDIGO guidelines for post-transplant monitoring and management of kidney transplant recipients 1
  • Research studies evaluating proteinuria measurement methods in transplant recipients 2, 3, 4, 5
  • Guidelines for recurrent disease management after transplantation 6, 7, 8

None of these sources contain information about:

  • Pre-transplant evaluation requirements at specific institutions
  • Institutional protocols for transplant candidate screening
  • Comparative practices between OHSU and UW transplant programs

What the Evidence Does Address

The KDIGO guidelines do recommend 24-hour urine testing after transplantation for monitoring purposes, including measuring urine volume every 1-2 hours for at least 24 hours after transplantation and measuring urine protein excretion at baseline and periodically thereafter 1. However, these are post-transplant monitoring recommendations, not pre-transplant evaluation requirements.

How to Obtain This Information

Contact the transplant programs directly at OHSU and UW to inquire about their specific pre-transplant evaluation protocols, as these requirements vary by institution and are not standardized in clinical practice guidelines.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014

Research

Use of the urinary protein creatinine index to assess proteinuria in renal transplant patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1992

Guideline

Recurrent IgA Nephropathy in Transplanted Kidneys: Monitoring and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medical Necessity of Daratumumab and Obinutuzumab for FSGS Recurrence Post-Kidney Transplant

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluación y Manejo de la Falla Tardía del Trasplante Renal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.